Article | 9/1/2012

Commercialization Alternatives in the New Medtech World

InVivo Magazine
Susan Posner, Vice President and Mark Speers, Partner and Managing Director
Health Advances outlines commercialization options for emerging medtech companies and the potential valuation and exit implications. Susan Posner, Vice President and Mark Speers, Partner and Managing Director, describe challenges that are emerging in the current industry climate that make early sales and commercialization decisions a critical component of a company’s overall strategy. Ultimately the strategy will not only drive sales and revenue but have a direct impact on exit valuations.
Read here.